Understanding observational studies in the time of COVID-19 webinar2020-06-23T11:34:33+00:00

Project Description

Understanding observational studies in the time of COVID-19 webinar 

Course overview

Venue: Free online training

Date: 30th June 2020

Time:  1430 – 1600 UK time (0930-1100 EDT/ 1530-1700 CEST)

Duration: 1.5 hours

This live session will be recorded.

Pharmacoepidemiology is a key discipline for understanding the safety of medicines, which has made important contributions to our understanding of drug safety. It is also being increasingly recognised as a practical tool for supporting risk management and planning safety activities at the time medicines are authorised. Expertise in pharmacoepidemiology is now a must for any research-based pharmaceutical company.

This free webinar is aimed at introducing delegates to the basic concepts of pharmacoepidemiology, with some topical COVID-19 examples.

If this whets your appetite, why not book a place on our full Introduction to Pharmacoepidemiology course, which takes place in November?

*Please note that the course dates and programme may be subject to change.

 Our courses are recognised by PharmaTrain.

Who should attend?

This course is aimed at:

  • Pharmaceutical industry personnel from areas including pharmacovigilance, clinical research, medical affairs,medical writing, regulatory affairs and medical information
  • Pharmaceutical physicians completing the Drug Safety Surveillance module of Pharmaceutical Medicine Specialty Training (PMST)
  • Staff from regulatory authorities
  • NHS, NHS R&D and other research organisations, doctors, nurses, medical information pharmacists, pharmaceutical advisors or other professions allied to medicine

Aims of course

  • To provide delegates with an introduction to the core principles of epidemiology
  • To explain the key methods used in pharmacoepidemiology
  • To show how epidemiological techniques are applied to pharmacoepidemiological studies on COVID-19 drugs

Learning Outcomes

On successful completion of this course delegates should be able to:

  • Have a good understanding of the definition and scope of epidemiology and pharmacoepidemiology
  • Explain the key methods used in pharmacoepidemiology
  • Understand how pharmacoepidemiology is used to monitor the safety of new COVID-19 drugs and vaccines

Key Topics

Programme features:

  • History and basic principles of epidemiology and pharmacoepidemiology
  • Basic concepts of pharmacoepidemiological methods
  • Use of pharmacoepidemiology to study the safety and effectiveness of COVID-19 drugs and vaccines



Contact Info

Drug Safety Research Unit Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, U.K.

Phone: +44 (0)23 80 40 86 00

Recent Posts